Unknown

Dataset Information

0

Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation.


ABSTRACT: Autophagy is closely related to tumor cell sensitivity to anticancer drugs. The HDAC (histone deacetylase) inhibitor valproic acid (VPA) interacted synergistically with chemotherapeutic agents to trigger lymphoma cell autophagy, which resulted from activation of AMPK (AMP-activated protein kinase) and inhibition of downstream MTOR (mechanistic target of rapamycin [serine/threonine kinase]) signaling. In an HDAC-independent manner, VPA potentiated the effect of doxorubicin on lymphoma cell autophagy via reduction of cellular inositol 1,4,5 trisphosphate (IP3), blockade of calcium into mitochondria and modulation of PRKAA1/2-MTOR cascade. In murine xenograft models established with subcutaneous injection of lymphoma cells, dual treatment of VPA and doxorubicin initiated IP3-mediated calcium depletion and PRKAA1/2 activation, induced in situ autophagy and efficiently retarded tumor growth. Aberrant genes involving mitochondrial calcium transfer were frequently observed in primary tumors of lymphoma patients. Collectively, these findings suggested an HDAC-independent chemosensitizing activity of VPA and provided an insight into the clinical application of targeting autophagy in the treatment of lymphoma.

SUBMITTER: Ji MM 

PROVIDER: S-EPMC4835147 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation.

Ji Meng-Meng MM   Wang Li L   Zhan Qin Q   Xue Wen W   Zhao Yan Y   Zhao Xia X   Xu Peng-Peng PP   Shen Yang Y   Liu Han H   Janin Anne A   Cheng Shu S   Zhao Wei-Li WL  

Autophagy 20150101 12


Autophagy is closely related to tumor cell sensitivity to anticancer drugs. The HDAC (histone deacetylase) inhibitor valproic acid (VPA) interacted synergistically with chemotherapeutic agents to trigger lymphoma cell autophagy, which resulted from activation of AMPK (AMP-activated protein kinase) and inhibition of downstream MTOR (mechanistic target of rapamycin [serine/threonine kinase]) signaling. In an HDAC-independent manner, VPA potentiated the effect of doxorubicin on lymphoma cell autoph  ...[more]

Similar Datasets

| S-EPMC2918577 | biostudies-literature
| S-EPMC6038315 | biostudies-literature
| S-EPMC2174455 | biostudies-literature
| S-EPMC5324848 | biostudies-literature
| S-EPMC5123689 | biostudies-literature
| S-EPMC4502672 | biostudies-literature
| S-EPMC10886669 | biostudies-literature
2024-09-26 | GSE185644 | GEO
| S-EPMC7923868 | biostudies-literature
| S-EPMC5909689 | biostudies-literature